<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Agents that inhibit leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> including intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 antibodies (anti-ICAM-1) have shown beneficial effects in experimental central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="1" ids="50845">Doxycycline</z:chebi> inhibits leukocyte function in vitro by binding divalent cations and reduces spinal cord reperfusion injury </plain></SENT>
<SENT sid="2" pm="."><plain>The authors used a clinically relevant model of focal <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> reperfusion injury to test whether treatment with <z:chebi fb="1" ids="50845">doxycycline</z:chebi> would reduce cerebral ischemic damage and improve functional outcome </plain></SENT>
<SENT sid="3" pm="."><plain>Reversible middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was produced in adult Sprague-Dawley rats by advancing a filament into the internal carotid artery for 2 h </plain></SENT>
<SENT sid="4" pm="."><plain>Animals received either i.p. <z:chebi fb="1" ids="50845">doxycycline</z:chebi> (10 mg/kg) (N = 13) or saline (N = 11) 30 min before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, followed by 10 mg/kg every 8 h x 6 </plain></SENT>
<SENT sid="5" pm="."><plain>Both functional assessment (5 point neurologic scale) and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was evaluated at 48 h </plain></SENT>
<SENT sid="6" pm="."><plain>Functional efficacy: <z:chebi fb="1" ids="50845">doxycycline</z:chebi> 0.5 +/- 0.2 (mean +/- SE) vs control 1.3 +/- 0.3 (p = 0.03) </plain></SENT>
<SENT sid="7" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume: <z:chebi fb="1" ids="50845">doxycycline</z:chebi> 56 +/- 18 mm3 vs control 158 +/- 44 mm3 (p = 0.03); This protective effect supports the role of <z:chebi fb="1" ids="50845">doxycycline</z:chebi> in reducing <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> reperfusion injury </plain></SENT>
</text></document>